Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.180
-0.030 (-0.71%)
Jul 9, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 7.54 billion as of July 9, 2026. Its market cap has decreased by -23.18% in one year.
Market Cap
7.54B
Enterprise Value
7.63B
Revenue
1.04B
Ranking
n/a
PE Ratio
25.22
Stock Price
4.18
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 7.54B, a decrease of -36.31%. That is a compound annual growth rate of -9.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.54B | -15.90% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TenNor Therapeutics (Suzhou) | 10.38B |
| HBM Holdings | 10.13B |
| Everest Medicines | 10.07B |
| Nanjing Leads Biolabs | 10.00B |
| CARsgen Therapeutics Holdings | 9.51B |
| Suzhou Ribo Life Science | 8.84B |
| CStone Pharmaceuticals | 8.73B |
| Abbisko Cayman | 8.30B |